西弗吉尼亚州甲型肝炎暴发期间相关医疗补助费用估算(2018-2019)
该分析评估了2018年1月1日至2019年7月31日西弗吉尼亚州 Medicaid 受益人中确诊甲型肝炎病毒感染者的总医疗费用。结果提示未遵循 ACIP 甲肝疫苗接种建议可能带来显著财政负担。
要点
- 未遵循 ACIP 接种建议(尤其针对非法药物使用者)可能增加财政负担。
核心结论
- 未遵循 ACIP 甲肝疫苗接种建议可能使辖区承担潜在财政费用。
研究设计与样本
- 对2018年1月1日至2019年7月31日西弗吉尼亚州 Medicaid 受益人中确诊甲肝病毒感染者进行费用分析。
关键数值与推荐
- ACIP 建议儿童及感染或重症风险增加者常规接种甲肝疫苗。
- ACIP 自1996年起建议非法药物使用者接种甲肝疫苗。
临床怎么用
- 对非法药物使用者等高风险人群按 ACIP 建议接种甲肝疫苗以阻断人际传播。
- 将疫苗接种作为公共卫生应对甲肝暴发和预防未来暴发的核心措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatitis A is a vaccine-preventable disease caused by the hepatitis A virus (HAV). Transmission of the virus most commonly occurs through the fecal-oral route after close contact with an infected person. Widespread outbreaks of hepatitis A among persons who use illicit drugs (injection and noninjection drugs) have increased in recent years (1). The Advisory Committee on Immunization Practices (ACIP) recommends routine hepatitis A vaccination for children and persons at increased risk for infection or severe disease, and, since 1996, has recommended hepatitis A vaccination for persons who use illicit drugs (2). Vaccinating persons who are at-risk for HAV infection is a mainstay of the public health response for stopping ongoing person-to-person transmission and preventing future outbreaks (1). In response to a large hepatitis A outbreak in West Virginia, an analysis was conducted to assess total hepatitis A-related medical costs during January 1, 2018-July 31, 2019, among West Virginia Medicaid beneficiaries with a confirmed diagnosis of HAV infection. Among the analysis population, direct clinical costs ranged from an estimated $1.4 million to $5.6 million. Direct clinical costs among a subset of the Medicaid population with a diagnosis of a comorbid substance use disorder ranged from an estimated $1.0 million to $4.4 million during the study period. In addition to insight on preventing illness, hospitalization, and death, the results from this study highlight the potential financial cost jurisdictions might incur when ACIP recommendations for hepatitis A vaccination, especially among persons who use illicit drugs, are not followed (2).
引用
- Batdorf SJ, Hofmeister MG, Surtees TC, et al. Estimated Medicaid Costs Associated with Hepatitis A During an Outbreak - West Virginia, 2018-2019. MMWR Morb Mortal Wkly Rep. 2021. PMID: 33630818. doi:10.15585/mmwr.mm7008a2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。